Would you be interested in helping us with this article focused on a type of treatment specifically targeting cancer cells for people with non-small cell lung cancer in people over 65?

I am looking for a consumer who would be willing to peer review this Cochrane systematic review “Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first line treatment of elderly people with advanced non-small cell lung cancer”.

Cochrane considers a consumer to be a person with experience of the condition (in this case, lung cancer), either as a patient or as a carer/family member of a patient. From a consumer perspective, we are interested if the language of the review, especially the language used in the Plain Language Summary, is accessible and if it feels relevant for those experiencing lung cancer, such that it will be helpful to patients and carers with healthcare decision making.

While you are welcome to provide feedback on any aspect of the review, you can focus your attention on the summary sections. Our aim is for this to be a manageable task, that does not overburden consumer reviewers.

Thank you in advance for considering!